Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3257467rdf:typepubmed:Citationlld:pubmed
pubmed-article:3257467lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:3257467lifeskim:mentionsumls-concept:C0080202lld:lifeskim
pubmed-article:3257467lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:3257467lifeskim:mentionsumls-concept:C0806140lld:lifeskim
pubmed-article:3257467lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:3257467lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:3257467pubmed:issue2lld:pubmed
pubmed-article:3257467pubmed:dateCreated1988-3-21lld:pubmed
pubmed-article:3257467pubmed:abstractTextThe influence of an ascites carcinoma on splenic T-cell subsets in normal or cyclophosphamide (Cy)-pretreated mice immunized with sheep erythrocytes was determined by immunophenotypic analysis, using an 'EPICS C' flow cytometer. As suggested by our previous studies on lymphokine production, the results obtained were consistent with direct impairment of Th-cell function and/or with tumour-induced suppression of cell-mediated immunity by Cy-insensitive suppressor cells, such as the 'Ts effector' (Ts3) or those of non-T-cell lineage.lld:pubmed
pubmed-article:3257467pubmed:languageenglld:pubmed
pubmed-article:3257467pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3257467pubmed:citationSubsetIMlld:pubmed
pubmed-article:3257467pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3257467pubmed:statusMEDLINElld:pubmed
pubmed-article:3257467pubmed:issn0020-5915lld:pubmed
pubmed-article:3257467pubmed:authorpubmed-author:ThomsonA WAWlld:pubmed
pubmed-article:3257467pubmed:authorpubmed-author:SewellH FHFlld:pubmed
pubmed-article:3257467pubmed:authorpubmed-author:TonnerEElld:pubmed
pubmed-article:3257467pubmed:issnTypePrintlld:pubmed
pubmed-article:3257467pubmed:volume85lld:pubmed
pubmed-article:3257467pubmed:ownerNLMlld:pubmed
pubmed-article:3257467pubmed:authorsCompleteYlld:pubmed
pubmed-article:3257467pubmed:pagination180-3lld:pubmed
pubmed-article:3257467pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:meshHeadingpubmed-meshheading:3257467-...lld:pubmed
pubmed-article:3257467pubmed:year1988lld:pubmed
pubmed-article:3257467pubmed:articleTitleCancer-induced alterations in T-cell subsets in normal and cyclophosphamide-treated mice. A flow cytometric analysis.lld:pubmed
pubmed-article:3257467pubmed:affiliationDepartment of Pathology, University of Aberdeen, UK.lld:pubmed
pubmed-article:3257467pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3257467pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed